| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 NCOA6 SATB1 ARID2 KAT6A MED12L TAF4 ARID1A MEF2A MED12 MEF2D HNRNPU | 1.94e-07 | 753 | 49 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 SATB1 EP400 ATXN7 KAT6A SMARCA2 ARID1A MEF2A MED12 PHC2 HNRNPU | 1.34e-06 | 739 | 49 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.60e-06 | 303 | 49 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.04e-05 | 582 | 49 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.11e-05 | 562 | 49 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.64e-05 | 417 | 49 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 YTHDF1 NCOA6 KAT6A TNRC6A MED12L SMARCA2 GIGYF2 ARID1A MED12 YTHDF3 HNRNPU | 8.03e-05 | 1356 | 49 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 YTHDF1 NCOA6 KAT6A TNRC6A MED12L SMARCA2 ARID1A MED12 YTHDF3 HNRNPU | 9.16e-05 | 1160 | 49 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.02e-04 | 37 | 49 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXJ2 SATB1 ZFHX4 FOXB2 ZFHX3 BATF3 ZNF319 MEF2A MED12 MEF2D HNRNPU | 1.70e-04 | 1244 | 49 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXJ2 SATB1 ZFHX4 FOXB2 ZFHX3 BATF3 ZNF319 MEF2A MED12 MEF2D HNRNPU | 2.06e-04 | 1271 | 49 | 11 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 3.20e-04 | 11 | 49 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 4.52e-04 | 61 | 49 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 6.07e-04 | 15 | 49 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXJ2 SATB1 ZFHX4 FOXB2 ZFHX3 BATF3 ZNF319 MEF2A MED12 MEF2D HNRNPU | 6.69e-04 | 1459 | 49 | 11 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 8.80e-04 | 18 | 49 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.14e-03 | 187 | 49 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.43e-03 | 694 | 49 | 7 | GO:0003729 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.57e-03 | 24 | 49 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 3.15e-03 | 34 | 49 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | lncRNA binding | 3.33e-03 | 35 | 49 | 2 | GO:0106222 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.74e-03 | 127 | 49 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 4.13e-03 | 39 | 49 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 4.64e-03 | 276 | 49 | 4 | GO:0003730 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 5.46e-03 | 45 | 49 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | miRNA binding | 6.19e-03 | 48 | 49 | 2 | GO:0035198 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 6.75e-03 | 1412 | 49 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | helicase activity | 6.86e-03 | 158 | 49 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | snRNA binding | 8.64e-03 | 57 | 49 | 2 | GO:0017069 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 FOXJ2 TET2 NCOA6 PPP2R5D ATXN7 ARID2 PAXIP1 MED12L SMARCA2 ZFHX3 TAF4 ZNF319 MEF2A MED12 MEF2D HNRNPU | 6.33e-09 | 1390 | 48 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 7.39e-09 | 259 | 48 | 9 | GO:1903313 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 2.31e-08 | 206 | 48 | 8 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 2.79e-08 | 211 | 48 | 8 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 2.79e-08 | 211 | 48 | 8 | GO:0061014 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 3.38e-07 | 292 | 48 | 8 | GO:0043488 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 5.07e-07 | 308 | 48 | 8 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 5.20e-07 | 309 | 48 | 8 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 7.16e-07 | 443 | 48 | 9 | GO:1903311 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 8.17e-07 | 139 | 48 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 2.13e-06 | 373 | 48 | 8 | GO:0006402 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 6.29e-06 | 432 | 48 | 8 | GO:0006401 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | YTHDF1 ZFP36L2 CELF3 TNRC6A PUM2 GIGYF2 TAF4 PUM1 YTHDF3 HNRNPU SCAF4 | 6.30e-06 | 917 | 48 | 11 | GO:0016071 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 SATB1 EP400 BICRA ARID2 KAT6A PAXIP1 SMARCA2 ARID1A HNRNPU | 6.40e-06 | 741 | 48 | 10 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 7.49e-06 | 54 | 48 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.06e-05 | 464 | 48 | 8 | GO:0141188 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA destabilization | 1.12e-05 | 19 | 48 | 3 | GO:0061158 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TET2 SATB1 EP400 BICRA ARID2 KAT6A PAXIP1 SMARCA2 TAF4 ARID1A HNRNPU | 1.41e-05 | 999 | 48 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.53e-05 | 231 | 48 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.65e-05 | 234 | 48 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.77e-05 | 237 | 48 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.99e-05 | 242 | 48 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 2.94e-05 | 701 | 48 | 9 | GO:0009896 | |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 SATB1 EP400 BICRA ARID2 KAT6A PAXIP1 SMARCA2 ARID1A HNRNPU | 3.31e-05 | 896 | 48 | 10 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 4.14e-05 | 29 | 48 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 4.28e-05 | 564 | 48 | 8 | GO:0051052 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 6.21e-05 | 92 | 48 | 4 | GO:0045661 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 7.04e-05 | 95 | 48 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 7.07e-05 | 186 | 48 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 8.00e-05 | 36 | 48 | 3 | GO:0034063 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 1.24e-04 | 845 | 48 | 9 | GO:0010564 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 1.27e-04 | 42 | 48 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.29e-04 | 111 | 48 | 4 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of translation | 1.36e-04 | 494 | 48 | 7 | GO:0006417 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.46e-04 | 44 | 48 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 1.85e-04 | 696 | 48 | 8 | GO:0034655 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 2.28e-04 | 51 | 48 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 2.81e-04 | 136 | 48 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | positive regulation of RIG-I signaling pathway | 2.88e-04 | 11 | 48 | 2 | GO:1900246 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 SATB1 KAT6A SMARCA2 ZFHX3 BATF3 ARID1A MEF2A PHC2 HNRNPU SCAF4 | 2.94e-04 | 1399 | 48 | 11 | GO:0045892 |
| GeneOntologyBiologicalProcess | DNA damage response | 3.19e-04 | 959 | 48 | 9 | GO:0006974 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 SATB1 KAT6A SMARCA2 ZFHX3 BATF3 ARID1A MEF2A PHC2 HNRNPU SCAF4 | 3.21e-04 | 1413 | 48 | 11 | GO:1902679 |
| GeneOntologyBiologicalProcess | nucleosome organization | 3.31e-04 | 142 | 48 | 4 | GO:0034728 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 3.40e-04 | 143 | 48 | 4 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA-mediated gene silencing | 3.45e-04 | 12 | 48 | 2 | GO:2000637 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 3.68e-04 | 146 | 48 | 4 | GO:2000779 | |
| GeneOntologyBiologicalProcess | positive regulation of post-transcriptional gene silencing by RNA | 4.07e-04 | 13 | 48 | 2 | GO:1900370 | |
| GeneOntologyBiologicalProcess | positive regulation of post-transcriptional gene silencing | 4.07e-04 | 13 | 48 | 2 | GO:0060148 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 4.36e-04 | 598 | 48 | 7 | GO:0080135 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 4.67e-04 | 65 | 48 | 3 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | EP400 ZFP36L2 ARID2 PAXIP1 SMARCA2 PUM2 GIGYF2 ARID1A PUM1 HNRNPU | 5.28e-04 | 1256 | 48 | 10 | GO:0051726 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 5.80e-04 | 70 | 48 | 3 | GO:0060261 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 6.99e-04 | 465 | 48 | 6 | GO:0007059 | |
| GeneOntologyBiologicalProcess | DNA repair | 7.03e-04 | 648 | 48 | 7 | GO:0006281 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 7.67e-04 | 77 | 48 | 3 | GO:2000144 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 7.81e-04 | 475 | 48 | 6 | GO:0140694 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 7.96e-04 | 78 | 48 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 8.57e-04 | 80 | 48 | 3 | GO:0045911 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 8.88e-04 | 81 | 48 | 3 | GO:0060260 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.03e-03 | 333 | 48 | 5 | GO:0051054 | |
| GeneOntologyBiologicalProcess | regulation of RIG-I signaling pathway | 1.08e-03 | 21 | 48 | 2 | GO:0039535 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 1.13e-03 | 88 | 48 | 3 | GO:0006289 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 1.19e-03 | 22 | 48 | 2 | GO:0006337 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 1.20e-03 | 516 | 48 | 6 | GO:1901987 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.20e-03 | 1153 | 48 | 9 | GO:0010608 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.24e-03 | 91 | 48 | 3 | GO:2000142 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.24e-03 | 91 | 48 | 3 | GO:0006446 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.41e-03 | 95 | 48 | 3 | GO:0030071 | |
| GeneOntologyBiologicalProcess | negative regulation of type I interferon-mediated signaling pathway | 1.42e-03 | 24 | 48 | 2 | GO:0060339 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 1.42e-03 | 24 | 48 | 2 | GO:0032986 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 1.51e-03 | 213 | 48 | 4 | GO:2000045 | |
| GeneOntologyBiologicalProcess | cell cycle process | FOXJ2 ZFP36L2 ARID2 PAXIP1 SMARCA2 PUM2 GIGYF2 ARID1A PUM1 HNRNPU | 1.52e-03 | 1441 | 48 | 10 | GO:0022402 |
| GeneOntologyBiologicalProcess | circulatory system development | FOXJ2 NCOA6 ARID2 KAT6A PAXIP1 SMARCA2 ARID1A MEF2A MED12 HNRNPU | 1.53e-03 | 1442 | 48 | 10 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.54e-03 | 98 | 48 | 3 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.63e-03 | 100 | 48 | 3 | GO:0007091 | |
| GeneOntologyBiologicalProcess | heart development | 1.73e-03 | 757 | 48 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.78e-03 | 103 | 48 | 3 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.79e-03 | 27 | 48 | 2 | GO:1900151 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 1.81e-03 | 1223 | 48 | 9 | GO:0030097 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.89e-03 | 382 | 48 | 5 | GO:0030217 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 2.03e-03 | 108 | 48 | 3 | GO:0035019 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 2.07e-03 | 29 | 48 | 2 | GO:0045948 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 2.13e-03 | 1252 | 48 | 9 | GO:0009894 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 2.19e-03 | 789 | 48 | 7 | GO:0002521 | |
| GeneOntologyBiologicalProcess | RIG-I signaling pathway | 2.21e-03 | 30 | 48 | 2 | GO:0039529 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.29e-03 | 239 | 48 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 2.36e-03 | 402 | 48 | 5 | GO:1901990 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 2.44e-03 | 594 | 48 | 6 | GO:0007346 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 2.55e-03 | 246 | 48 | 4 | GO:1902806 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 2.67e-03 | 33 | 48 | 2 | GO:2000737 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.75e-03 | 1053 | 48 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | translation | 2.79e-03 | 824 | 48 | 7 | GO:0006412 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell homeostasis | 2.84e-03 | 34 | 48 | 2 | GO:0061484 | |
| GeneOntologyBiologicalProcess | regulation of miRNA-mediated gene silencing | 2.84e-03 | 34 | 48 | 2 | GO:0060964 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 2.86e-03 | 254 | 48 | 4 | GO:0000819 | |
| GeneOntologyBiologicalProcess | regulation of post-transcriptional gene silencing by regulatory ncRNA | 3.18e-03 | 36 | 48 | 2 | GO:1900368 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 3.19e-03 | 627 | 48 | 6 | GO:0044770 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 3.23e-03 | 1081 | 48 | 8 | GO:0006259 | |
| GeneOntologyBiologicalProcess | regulation of post-transcriptional gene silencing | 3.35e-03 | 37 | 48 | 2 | GO:0060147 | |
| GeneOntologyCellularComponent | chromatin | FOXJ2 SATB1 ZFHX4 EP400 ATXN7 BICRA ARID2 KAT6A FOXB2 SMARCA2 ZFHX3 BATF3 TAF4 ARID1A MEF2A MEF2D PHC2 | 1.90e-08 | 1480 | 49 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.94e-07 | 269 | 49 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 3.17e-07 | 287 | 49 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 NCOA6 EP400 ATXN7 BICRA ARID2 PAXIP1 MED12L SMARCA2 BATF3 TAF4 ARID1A MED12 PHC2 HNRNPU | 3.31e-07 | 1377 | 49 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF complex | 6.98e-07 | 30 | 49 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.99e-06 | 96 | 49 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.99e-06 | 96 | 49 | 5 | GO:0010494 | |
| GeneOntologyCellularComponent | transcription regulator complex | 8.70e-06 | 596 | 49 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | ATPase complex | 1.27e-05 | 129 | 49 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.89e-05 | 140 | 49 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 4.92e-05 | 171 | 49 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | transferase complex | NCOA6 EP400 ATXN7 KAT6A PAXIP1 RANBP9 FBXO11 TAF4 MED12 PHC2 | 6.56e-05 | 963 | 49 | 10 | GO:1990234 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.96e-05 | 94 | 49 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | P-body | 9.56e-05 | 102 | 49 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.03e-04 | 104 | 49 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.24e-04 | 109 | 49 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | bBAF complex | 2.39e-04 | 10 | 49 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.50e-04 | 12 | 49 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 3.76e-04 | 972 | 49 | 9 | GO:0140535 | |
| GeneOntologyCellularComponent | npBAF complex | 4.81e-04 | 14 | 49 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 4.81e-04 | 14 | 49 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 4.81e-04 | 14 | 49 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 6.33e-04 | 16 | 49 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 7.26e-04 | 75 | 49 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | transcription factor TFTC complex | 8.04e-04 | 18 | 49 | 2 | GO:0033276 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.08e-03 | 108 | 49 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | mediator complex | 3.40e-03 | 37 | 49 | 2 | GO:0016592 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.75e-03 | 272 | 49 | 4 | GO:0090575 | |
| GeneOntologyCellularComponent | SAGA-type complex | 3.77e-03 | 39 | 49 | 2 | GO:0070461 | |
| GeneOntologyCellularComponent | nuclear body | 4.83e-03 | 903 | 49 | 7 | GO:0016604 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 9.23e-03 | 352 | 49 | 4 | GO:0000151 | |
| HumanPheno | Abnormal nasal tip morphology | PACS1 BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 ARID1A MED12 SCAF4 | 1.10e-07 | 386 | 26 | 12 | HP:0000436 |
| HumanPheno | Bulbous nose | 3.38e-07 | 201 | 26 | 9 | HP:0000414 | |
| HumanPheno | Diagnostic behavioral phenotype | PACS1 PPP2R5D SATB1 BICRA ARID2 KAT6A MED12L SMARCA2 GIGYF2 FBXO11 QRICH1 TAF4 ARID1A MED12 SCAF4 | 4.34e-07 | 747 | 26 | 15 | HP:0025783 |
| HumanPheno | Macrostomia | 7.31e-07 | 220 | 26 | 9 | HP:0000181 | |
| HumanPheno | Wide mouth | 7.31e-07 | 220 | 26 | 9 | HP:0000154 | |
| HumanPheno | Abnormality of upper lip vermillion | PACS1 PPP2R5D ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 ARID1A MED12 HNRNPU | 8.36e-07 | 464 | 26 | 12 | HP:0011339 |
| HumanPheno | Abnormal eyebrow morphology | PACS1 SATB1 BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 TAF4 ARID1A PUM1 MED12 HNRNPU | 9.21e-07 | 674 | 26 | 14 | HP:0000534 |
| HumanPheno | Autistic behavior | PACS1 PPP2R5D SATB1 BICRA ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 ARID1A MED12 SCAF4 | 9.91e-07 | 678 | 26 | 14 | HP:0000729 |
| HumanPheno | Low frustration tolerance | 1.56e-06 | 18 | 26 | 4 | HP:0000744 | |
| HumanPheno | Abnormal lower lip morphology | 1.63e-06 | 242 | 26 | 9 | HP:0000178 | |
| HumanPheno | Abnormality of the philtrum | PACS1 PPP2R5D SATB1 ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 ARID1A MED12 HNRNPU SCAF4 | 2.31e-06 | 726 | 26 | 14 | HP:0000288 |
| HumanPheno | Smooth philtrum | 2.32e-06 | 185 | 26 | 8 | HP:0000319 | |
| HumanPheno | Thin upper lip vermilion | PACS1 PPP2R5D ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 ARID1A MED12 | 3.04e-06 | 339 | 26 | 10 | HP:0000219 |
| HumanPheno | Thin lips | PACS1 PPP2R5D ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 ARID1A MED12 | 3.04e-06 | 339 | 26 | 10 | HP:0000213 |
| HumanPheno | Thin vermilion border | PACS1 PPP2R5D ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 ARID1A MED12 HNRNPU | 3.52e-06 | 433 | 26 | 11 | HP:0000233 |
| HumanPheno | Thick lower lip vermilion | 3.57e-06 | 136 | 26 | 7 | HP:0000179 | |
| HumanPheno | High palate | PPP2R5D BICRA ARID2 MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 HNRNPU SCAF4 | 6.89e-06 | 794 | 26 | 14 | HP:0000218 |
| HumanPheno | Abnormality of the frontal hairline | 7.16e-06 | 215 | 26 | 8 | HP:0000599 | |
| HumanPheno | Thick eyebrow | 8.17e-06 | 154 | 26 | 7 | HP:0000574 | |
| HumanPheno | Prominent lips | 8.90e-06 | 156 | 26 | 7 | HP:0000184 | |
| HumanPheno | Delayed ability to walk | 1.08e-05 | 304 | 26 | 9 | HP:0031936 | |
| HumanPheno | Downslanted palpebral fissures | PACS1 PPP2R5D SATB1 BICRA ARID2 MED12L SMARCA2 KCNN3 FBXO11 TAF4 MED12 | 1.35e-05 | 497 | 26 | 11 | HP:0000494 |
| HumanPheno | Slanting of the palpebral fissure | PACS1 PPP2R5D SATB1 BICRA ARID2 MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 MED12 HNRNPU | 1.90e-05 | 739 | 26 | 13 | HP:0200006 |
| HumanPheno | Recurrent maladaptive behavior | TET2 PACS1 PPP2R5D SATB1 ATXN7 BICRA ARID2 KAT6A MED12L SMARCA2 GIGYF2 FBXO11 TAF4 ARID1A PUM1 MED12 SCAF4 | 1.92e-05 | 1293 | 26 | 17 | HP:5200241 |
| HumanPheno | Congenital abnormal hair pattern | 1.95e-05 | 327 | 26 | 9 | HP:0011361 | |
| HumanPheno | Abnormality of mouth size | PACS1 ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 ARID1A MED12 | 2.30e-05 | 425 | 26 | 10 | HP:0011337 |
| HumanPheno | Hypertrichosis | PACS1 BICRA ARID2 SMARCA2 KCNN3 FBXO11 TAF4 ARID1A PUM1 HNRNPU | 2.30e-05 | 425 | 26 | 10 | HP:0000998 |
| HumanPheno | Abnormality of the palpebral fissures | PACS1 PPP2R5D SATB1 BICRA ARID2 MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 PUM1 MED12 HNRNPU | 2.36e-05 | 880 | 26 | 14 | HP:0008050 |
| HumanPheno | Short philtrum | 2.37e-05 | 253 | 26 | 8 | HP:0000322 | |
| HumanPheno | Narrow palpebral fissure | 2.39e-05 | 71 | 26 | 5 | HP:0045025 | |
| HumanPheno | Long eyelashes | 3.56e-05 | 129 | 26 | 6 | HP:0000527 | |
| HumanPheno | Abnormal external nose morphology | PACS1 BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 SCAF4 | 3.78e-05 | 916 | 26 | 14 | HP:0010938 |
| HumanPheno | Thick nasal alae | 3.89e-05 | 39 | 26 | 4 | HP:0009928 | |
| HumanPheno | Joint hypermobility | SATB1 BICRA ARID2 SMARCA2 KCNN3 FBXO11 TAF4 ARID1A PUM1 MED12 SCAF4 | 4.02e-05 | 557 | 26 | 11 | HP:0001382 |
| HumanPheno | Abnormal hair pattern | PACS1 SATB1 BICRA ARID2 SMARCA2 KCNN3 FBXO11 TAF4 ARID1A PUM1 MED12 HNRNPU | 4.41e-05 | 676 | 26 | 12 | HP:0010720 |
| HumanPheno | Pes planus | 4.71e-05 | 365 | 26 | 9 | HP:0001763 | |
| HumanPheno | Motor stereotypy | 4.94e-05 | 280 | 26 | 8 | HP:0000733 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 5.03e-05 | 368 | 26 | 9 | HP:0031432 | |
| HumanPheno | Abnormal eyelash morphology | 5.47e-05 | 284 | 26 | 8 | HP:0000499 | |
| HumanPheno | Constipation | PACS1 SATB1 BICRA ARID2 MED12L SMARCA2 GIGYF2 FBXO11 TAF4 MED12 | 5.75e-05 | 472 | 26 | 10 | HP:0002019 |
| HumanPheno | Perseverative thought | 6.09e-05 | 377 | 26 | 9 | HP:0030223 | |
| HumanPheno | Abnormal eyelid morphology | PACS1 PPP2R5D SATB1 BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 HNRNPU SCAF4 | 6.39e-05 | 1408 | 26 | 17 | HP:0000492 |
| HumanPheno | Broad philtrum | 6.90e-05 | 45 | 26 | 4 | HP:0000289 | |
| HumanPheno | Abnormality of the hairline | 7.01e-05 | 294 | 26 | 8 | HP:0009553 | |
| HumanPheno | Disordered formal thought process | 7.34e-05 | 386 | 26 | 9 | HP:0025769 | |
| HumanPheno | Low anterior hairline | 7.45e-05 | 147 | 26 | 6 | HP:0000294 | |
| HumanPheno | Oral aversion | 7.66e-05 | 17 | 26 | 3 | HP:0012523 | |
| HumanPheno | Abnormal upper lip morphology | PACS1 PPP2R5D SATB1 ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 ARID1A MED12 HNRNPU SCAF4 | 8.27e-05 | 980 | 26 | 14 | HP:0000177 |
| HumanPheno | Delayed speech and language development | PACS1 PPP2R5D SATB1 ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 HNRNPU SCAF4 | 8.29e-05 | 1123 | 26 | 15 | HP:0000750 |
| HumanPheno | Sparse eyebrow | 8.65e-05 | 151 | 26 | 6 | HP:0045075 | |
| HumanPheno | Short phalanx of finger | 9.32e-05 | 306 | 26 | 8 | HP:0009803 | |
| HumanPheno | Sandal gap | 1.03e-04 | 96 | 26 | 5 | HP:0001852 | |
| HumanPheno | Abnormal morphology of the great vessels | PACS1 BICRA ARID2 KAT6A SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A MED12 SCAF4 | 1.04e-04 | 736 | 26 | 12 | HP:0030962 |
| HumanPheno | Abnormal thought pattern | 1.05e-04 | 404 | 26 | 9 | HP:5200269 | |
| HumanPheno | Abnormal columella morphology | 1.08e-04 | 97 | 26 | 5 | HP:0009929 | |
| HumanPheno | Hypoplastic fifth toenail | 1.08e-04 | 19 | 26 | 3 | HP:0011937 | |
| HumanPheno | Abnormally increased volition | PACS1 PPP2R5D SATB1 ATXN7 ARID2 MED12L SMARCA2 GIGYF2 FBXO11 TAF4 ARID1A MED12 SCAF4 | 1.11e-04 | 869 | 26 | 13 | HP:5200263 |
| HumanPheno | Broad nasal tip | 1.15e-04 | 159 | 26 | 6 | HP:0000455 | |
| HumanPheno | Aggressive behavior | PACS1 PPP2R5D ARID2 MED12L SMARCA2 GIGYF2 TAF4 ARID1A MED12 SCAF4 | 1.23e-04 | 516 | 26 | 10 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | PACS1 PPP2R5D ARID2 MED12L SMARCA2 GIGYF2 TAF4 ARID1A MED12 SCAF4 | 1.23e-04 | 516 | 26 | 10 | HP:0006919 |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 1.25e-04 | 319 | 26 | 8 | HP:0009767 | |
| HumanPheno | Motor delay | PPP2R5D SATB1 ATXN7 ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 PUM1 TFG MED12 SCAF4 | 1.28e-04 | 1018 | 26 | 14 | HP:0001270 |
| HumanPheno | Pectus excavatum | 1.36e-04 | 323 | 26 | 8 | HP:0000767 | |
| HumanPheno | Prominent nasal bridge | 1.40e-04 | 239 | 26 | 7 | HP:0000426 | |
| HumanPheno | Abnormal morphology of the nasal alae | BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A MED12 | 1.44e-04 | 639 | 26 | 11 | HP:0000429 |
| HumanPheno | Language impairment | PACS1 PPP2R5D SATB1 ARID2 KAT6A MED12L SMARCA2 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 HNRNPU SCAF4 | 1.48e-04 | 1178 | 26 | 15 | HP:0002463 |
| HumanPheno | Reduced impulse control | TET2 PACS1 PPP2R5D SATB1 ATXN7 ARID2 MED12L SMARCA2 GIGYF2 FBXO11 TAF4 ARID1A MED12 SCAF4 | 1.49e-04 | 1032 | 26 | 14 | HP:5200045 |
| HumanPheno | Triangular face | 1.51e-04 | 167 | 26 | 6 | HP:0000325 | |
| HumanPheno | Low hanging columella | 1.64e-04 | 56 | 26 | 4 | HP:0009765 | |
| HumanPheno | Brachydactyly (hand) | 1.70e-04 | 430 | 26 | 9 | HP:0100667 | |
| HumanPheno | Absent speech | 1.89e-04 | 436 | 26 | 9 | HP:0001344 | |
| HumanPheno | Abnormal palate morphology | PPP2R5D BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 HNRNPU SCAF4 | 1.89e-04 | 1202 | 26 | 15 | HP:0000174 |
| HumanPheno | Prominent nose | 1.96e-04 | 110 | 26 | 5 | HP:0000448 | |
| HumanPheno | Abnormal curvature of the vertebral column | PACS1 PPP2R5D SATB1 BICRA ARID2 MED12L SMARCA2 KCNN3 QRICH1 TAF4 ARID1A PUM1 MED12 HNRNPU SCAF4 | 2.24e-04 | 1219 | 26 | 15 | HP:0010674 |
| HumanPheno | Abnormal esophagus physiology | PACS1 PPP2R5D SATB1 ATXN7 BICRA ARID2 KAT6A MED12L SMARCA2 GIGYF2 FBXO11 TFG MED12 | 2.35e-04 | 933 | 26 | 13 | HP:0025270 |
| HumanPheno | Abnormal nasal septum morphology | 2.42e-04 | 115 | 26 | 5 | HP:0000419 | |
| HumanPheno | Anteverted nares | BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A | 2.42e-04 | 559 | 26 | 10 | HP:0000463 |
| HumanPheno | Upturned nose | BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A | 2.42e-04 | 559 | 26 | 10 | HP:0000427 |
| HumanPheno | Abnormal esophagus morphology | PACS1 PPP2R5D SATB1 ATXN7 BICRA ARID2 KAT6A MED12L SMARCA2 GIGYF2 FBXO11 TFG MED12 SCAF4 | 2.44e-04 | 1078 | 26 | 14 | HP:0002031 |
| HumanPheno | Sparse medial eyebrow | 2.48e-04 | 5 | 26 | 2 | HP:0025325 | |
| HumanPheno | Aplastic/hypoplastic toenail | 2.62e-04 | 117 | 26 | 5 | HP:0010624 | |
| HumanPheno | Deviation of toes | 2.73e-04 | 118 | 26 | 5 | HP:0100498 | |
| HumanPheno | Abnormal lip morphology | PACS1 PPP2R5D SATB1 ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A MED12 HNRNPU SCAF4 | 2.99e-04 | 1249 | 26 | 15 | HP:0000159 |
| HumanPheno | Deficiency of speech development | 2.99e-04 | 463 | 26 | 9 | HP:0002116 | |
| HumanPheno | Clinodactyly | PACS1 ARID2 SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A PUM1 MED12 | 3.02e-04 | 574 | 26 | 10 | HP:0030084 |
| HumanPheno | Abnormal nostril morphology | BICRA ARID2 KAT6A MED12L SMARCA2 KCNN3 FBXO11 QRICH1 TAF4 ARID1A | 3.06e-04 | 575 | 26 | 10 | HP:0005288 |
| HumanPheno | Synophrys | 3.53e-04 | 195 | 26 | 6 | HP:0000664 | |
| HumanPheno | Wide nasal base | 3.55e-04 | 28 | 26 | 3 | HP:0012810 | |
| HumanPheno | Thick vermilion border | 3.66e-04 | 279 | 26 | 7 | HP:0012471 | |
| HumanPheno | Abnormality of refraction | PACS1 PPP2R5D SATB1 BICRA ARID2 KAT6A MED12L FBXO11 TAF4 ARID1A MED12 | 3.70e-04 | 709 | 26 | 11 | HP:0000539 |
| HumanPheno | Upper eyelid edema | 3.71e-04 | 6 | 26 | 2 | HP:0012724 | |
| HumanPheno | Prominent interphalangeal joints | 3.71e-04 | 6 | 26 | 2 | HP:0006237 | |
| HumanPheno | Delayed gross motor development | 3.99e-04 | 481 | 26 | 9 | HP:0002194 | |
| HumanPheno | Insomnia | 4.11e-04 | 71 | 26 | 4 | HP:0100785 | |
| HumanPheno | Wide nose | 4.13e-04 | 129 | 26 | 5 | HP:0000445 | |
| HumanPheno | Abnormal nasal base norphology | 4.37e-04 | 30 | 26 | 3 | HP:0012808 | |
| HumanPheno | Abnormal periauricular region morphology | 4.44e-04 | 131 | 26 | 5 | HP:0000383 | |
| HumanPheno | Highly arched eyebrow | 4.75e-04 | 206 | 26 | 6 | HP:0002553 | |
| HumanPheno | Facial hypertrichosis | 4.75e-04 | 206 | 26 | 6 | HP:0002219 | |
| HumanPheno | Plagiocephaly | 5.00e-04 | 208 | 26 | 6 | HP:0001357 | |
| Domain | Mediator_Med12_catenin-bd | 6.47e-06 | 2 | 48 | 2 | IPR021989 | |
| Domain | Pumilio_RNA-bd | 6.47e-06 | 2 | 48 | 2 | IPR033712 | |
| Domain | Med12-PQL | 6.47e-06 | 2 | 48 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 6.47e-06 | 2 | 48 | 2 | PF12145 | |
| Domain | Mediator_Med12 | 6.47e-06 | 2 | 48 | 2 | IPR019035 | |
| Domain | Med12 | 6.47e-06 | 2 | 48 | 2 | SM01281 | |
| Domain | Med12 | 6.47e-06 | 2 | 48 | 2 | PF09497 | |
| Domain | Mediator_Med12_LCEWAV | 6.47e-06 | 2 | 48 | 2 | IPR021990 | |
| Domain | PUM-HD | 1.94e-05 | 3 | 48 | 2 | IPR033133 | |
| Domain | PUF | 1.94e-05 | 3 | 48 | 2 | PF00806 | |
| Domain | PUM_HD | 1.94e-05 | 3 | 48 | 2 | PS50303 | |
| Domain | Pumilio_RNA-bd_rpt | 3.87e-05 | 4 | 48 | 2 | IPR001313 | |
| Domain | HSA | 3.87e-05 | 4 | 48 | 2 | SM00573 | |
| Domain | HJURP_C | 3.87e-05 | 4 | 48 | 2 | IPR022102 | |
| Domain | HSA | 3.87e-05 | 4 | 48 | 2 | PS51204 | |
| Domain | HSA_dom | 3.87e-05 | 4 | 48 | 2 | IPR014012 | |
| Domain | HJURP_C | 3.87e-05 | 4 | 48 | 2 | PF12347 | |
| Domain | PUM | 3.87e-05 | 4 | 48 | 2 | PS50302 | |
| Domain | HSA | 3.87e-05 | 4 | 48 | 2 | PF07529 | |
| Domain | MADS_MEF2-like | 3.87e-05 | 4 | 48 | 2 | IPR033896 | |
| Domain | Pumilio | 3.87e-05 | 4 | 48 | 2 | SM00025 | |
| Domain | YTH | 6.44e-05 | 5 | 48 | 2 | PS50882 | |
| Domain | YTH_domain | 6.44e-05 | 5 | 48 | 2 | IPR007275 | |
| Domain | YTH | 6.44e-05 | 5 | 48 | 2 | PF04146 | |
| Domain | MADS | 9.64e-05 | 6 | 48 | 2 | SM00432 | |
| Domain | MADS_BOX_1 | 9.64e-05 | 6 | 48 | 2 | PS00350 | |
| Domain | SRF-TF | 9.64e-05 | 6 | 48 | 2 | PF00319 | |
| Domain | MADS_BOX_2 | 9.64e-05 | 6 | 48 | 2 | PS50066 | |
| Domain | TF_MADSbox | 1.35e-04 | 7 | 48 | 2 | IPR002100 | |
| Domain | ARM-like | 6.27e-04 | 270 | 48 | 5 | IPR011989 | |
| Domain | - | 6.65e-04 | 15 | 48 | 2 | 1.10.150.60 | |
| Domain | ARID | 6.65e-04 | 15 | 48 | 2 | PF01388 | |
| Domain | BRIGHT | 6.65e-04 | 15 | 48 | 2 | SM00501 | |
| Domain | ARID_dom | 6.65e-04 | 15 | 48 | 2 | IPR001606 | |
| Domain | ARID | 6.65e-04 | 15 | 48 | 2 | PS51011 | |
| Domain | Homeodomain-like | 1.58e-03 | 332 | 48 | 5 | IPR009057 | |
| Domain | ARM-type_fold | 1.73e-03 | 339 | 48 | 5 | IPR016024 | |
| Domain | - | 2.35e-03 | 218 | 48 | 4 | 1.10.10.10 | |
| Domain | - | 2.51e-03 | 222 | 48 | 4 | 1.25.10.10 | |
| Domain | ZnF_U1 | 2.51e-03 | 29 | 48 | 2 | SM00451 | |
| Domain | Znf_U1 | 2.51e-03 | 29 | 48 | 2 | IPR003604 | |
| Domain | SNF2_N | 3.05e-03 | 32 | 48 | 2 | PF00176 | |
| Domain | SNF2_N | 3.05e-03 | 32 | 48 | 2 | IPR000330 | |
| Domain | WHTH_DNA-bd_dom | 3.42e-03 | 242 | 48 | 4 | IPR011991 | |
| Domain | MYB_LIKE | 4.29e-03 | 38 | 48 | 2 | PS50090 | |
| Domain | - | 4.74e-03 | 40 | 48 | 2 | 4.10.1000.10 | |
| Domain | TF_fork_head_CS_2 | 6.23e-03 | 46 | 48 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 6.49e-03 | 47 | 48 | 2 | IPR018122 | |
| Domain | ZnF_C3H1 | 6.77e-03 | 48 | 48 | 2 | SM00356 | |
| Domain | zf-CCCH | 7.04e-03 | 49 | 48 | 2 | PF00642 | |
| Domain | FORK_HEAD_3 | 7.04e-03 | 49 | 48 | 2 | PS50039 | |
| Domain | FH | 7.04e-03 | 49 | 48 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 7.04e-03 | 49 | 48 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 7.04e-03 | 49 | 48 | 2 | PS00658 | |
| Domain | Forkhead | 7.04e-03 | 49 | 48 | 2 | PF00250 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 8.13e-07 | 29 | 36 | 4 | M48076 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.23e-06 | 37 | 36 | 4 | M27797 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.85e-05 | 272 | 36 | 6 | M29619 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.02e-04 | 301 | 36 | 6 | MM15983 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA6 ZFP36L2 SPRR1A TNRC6A PAXIP1 RANBP9 SMARCA2 ARID1A MEF2A MED12 MEF2D HNRNPU | 1.41e-04 | 1432 | 36 | 12 | M509 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.17e-04 | 237 | 36 | 5 | M27786 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 4.36e-04 | 254 | 36 | 5 | M27131 | |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 4.51e-04 | 59 | 36 | 3 | M39579 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 4.97e-04 | 61 | 36 | 3 | M152 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.99e-04 | 65 | 36 | 3 | M39682 | |
| Pathway | WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION | 9.46e-04 | 18 | 36 | 2 | M39393 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.02e-03 | 78 | 36 | 3 | M27234 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.42e-03 | 22 | 36 | 2 | M13408 | |
| Pubmed | TRERF1 YTHDF1 TET2 NCOA6 SATB1 ZFHX4 EP400 ATXN7 BICRA ARID2 TNRC6A PAXIP1 SMARCA2 PUM2 GIGYF2 HELZ ZFHX3 TAF4 ZNF319 ARID1A PUM1 MEF2A MEF2D YTHDF3 SCAF4 | 4.39e-22 | 1429 | 49 | 25 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 TET2 NCOA6 SATB1 ZFHX4 EP400 BICRA ARID2 PAXIP1 SMARCA2 ZFHX3 TAF4 ARID1A MED12 YTHDF3 | 9.83e-19 | 351 | 49 | 15 | 38297188 |
| Pubmed | 5.64e-13 | 23 | 49 | 6 | 9225980 | ||
| Pubmed | TRERF1 TET2 NCOA6 EP400 BICRA ARID2 PAXIP1 SMARCA2 QRICH1 TAF4 ARID1A MEF2A MED12 MEF2D HNRNPU SCAF4 | 1.18e-12 | 1103 | 49 | 16 | 34189442 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | YTHDF1 NCOA6 TNRC6A SMARCA2 PUM2 HELZ QRICH1 ARID1A PUM1 TFG MEF2D YTHDF3 | 1.36e-12 | 457 | 49 | 12 | 32344865 |
| Pubmed | TRERF1 TET2 NCOA6 EP400 PAXIP1 SMARCA2 ARID1A MEF2A MED12 MEF2D | 3.94e-12 | 268 | 49 | 10 | 33640491 | |
| Pubmed | NCOA6 EP400 ARID2 RANBP9 SMARCA2 ARID1A TFG MED12 MEF2D YTHDF3 SCAF4 | 4.69e-11 | 472 | 49 | 11 | 38943005 | |
| Pubmed | ZFHX4 EP400 PHLDA1 ATXN7 BICRA ARID2 KAT6A TNRC6A RANBP9 SMARCA2 HELZ ZFHX3 TAF4 ARID1A | 2.68e-10 | 1116 | 49 | 14 | 31753913 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | YTHDF1 NCOA6 EP400 BICRA ARID2 GIGYF2 TAF4 ARID1A PUM1 MEF2D YTHDF3 HNRNPU SCAF4 | 4.84e-10 | 954 | 49 | 13 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 PACS1 NCOA6 EP400 ATXN7 SMARCA2 PUM2 GIGYF2 HELZ MEF2D PHC2 SCAF4 | 5.89e-10 | 774 | 49 | 12 | 15302935 |
| Pubmed | 1.58e-09 | 80 | 49 | 6 | 35803934 | ||
| Pubmed | 2.45e-09 | 157 | 49 | 7 | 30186101 | ||
| Pubmed | 5.72e-09 | 282 | 49 | 8 | 23667531 | ||
| Pubmed | 9.24e-09 | 107 | 49 | 6 | 30995489 | ||
| Pubmed | EP400 ZFP36L2 ATXN7 ARID2 TNRC6A SMARCA2 PUM2 HELZ FBXO11 ZFHX3 TAF4 MED12 PHC2 SCAF4 | 1.16e-08 | 1497 | 49 | 14 | 31527615 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.53e-08 | 462 | 49 | 9 | 31138677 | |
| Pubmed | 2.18e-08 | 335 | 49 | 8 | 15741177 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 5.45e-08 | 536 | 49 | 9 | 15840001 | |
| Pubmed | 5.63e-08 | 538 | 49 | 9 | 10512203 | ||
| Pubmed | 5.96e-08 | 27 | 49 | 4 | 29374058 | ||
| Pubmed | 8.05e-08 | 29 | 49 | 4 | 19279220 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 8.21e-08 | 398 | 49 | 8 | 35016035 | |
| Pubmed | 1.19e-07 | 418 | 49 | 8 | 34709266 | ||
| Pubmed | 1.20e-07 | 83 | 49 | 5 | 28794006 | ||
| Pubmed | TRERF1 FOXJ2 SATB1 ZFP36L2 ARID2 SMARCA2 ZFHX3 ARID1A MEF2A MEF2D | 1.57e-07 | 808 | 49 | 10 | 20412781 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.89e-07 | 444 | 49 | 8 | 34795231 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXJ2 SATB1 ZFHX4 EP400 FBXO11 BATF3 QRICH1 PUM1 MEF2A MEF2D | 2.70e-07 | 857 | 49 | 10 | 25609649 |
| Pubmed | 2.96e-07 | 655 | 49 | 9 | 35819319 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 3.13e-07 | 10 | 49 | 3 | 23129809 | |
| Pubmed | 3.75e-07 | 486 | 49 | 8 | 20936779 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.94e-07 | 341 | 49 | 7 | 32971831 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 5.26e-07 | 922 | 49 | 10 | 27609421 | |
| Pubmed | 7.56e-07 | 733 | 49 | 9 | 34672954 | ||
| Pubmed | 9.36e-07 | 549 | 49 | 8 | 38280479 | ||
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 9.46e-07 | 14 | 49 | 3 | 8895581 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.49e-06 | 59 | 49 | 4 | 28813667 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.67e-06 | 807 | 49 | 9 | 22681889 | |
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 11078522 | ||
| Pubmed | ZFP36L2 BICRA ARID2 PAXIP1 PHLPP1 GIGYF2 HELZ FBXO11 QRICH1 TAF4 MED12 | 1.84e-06 | 1327 | 49 | 11 | 32694731 | |
| Pubmed | MEF2 negatively regulates learning-induced structural plasticity and memory formation. | 1.94e-06 | 2 | 49 | 2 | 22885849 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28106076 | ||
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 1.94e-06 | 2 | 49 | 2 | 10873665 | |
| Pubmed | Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury. | 1.94e-06 | 2 | 49 | 2 | 39081030 | |
| Pubmed | A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins. | 1.94e-06 | 2 | 49 | 2 | 31078383 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32753408 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11318604 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12459267 | ||
| Pubmed | PUMILIO proteins promote colorectal cancer growth via suppressing p21. | 1.94e-06 | 2 | 49 | 2 | 35338151 | |
| Pubmed | Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. | 1.94e-06 | 2 | 49 | 2 | 29165587 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32437472 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 35507203 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26517885 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12667987 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12771951 | ||
| Pubmed | Alternate modes of cognate RNA recognition by human PUMILIO proteins. | 1.94e-06 | 2 | 49 | 2 | 21397187 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18776931 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31722213 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30699340 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8798771 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32316190 | ||
| Pubmed | Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes. | 1.94e-06 | 2 | 49 | 2 | 32512162 | |
| Pubmed | 2.21e-06 | 65 | 49 | 4 | 22496869 | ||
| Pubmed | 2.28e-06 | 272 | 49 | 6 | 31010829 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 2.51e-06 | 19 | 49 | 3 | 12110891 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 EP400 ZFP36L2 BICRA KAT6A PAXIP1 ARID1A PUM1 MED12 PHC2 | 2.68e-06 | 1105 | 49 | 10 | 35748872 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 2.81e-06 | 69 | 49 | 4 | 28481362 | |
| Pubmed | 2.94e-06 | 446 | 49 | 7 | 24255178 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 4.36e-06 | 908 | 49 | 9 | 19274049 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 4.56e-06 | 23 | 49 | 3 | 8804307 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 4.56e-06 | 23 | 49 | 3 | 30962207 | |
| Pubmed | 5.21e-06 | 24 | 49 | 3 | 37543677 | ||
| Pubmed | 5.21e-06 | 24 | 49 | 3 | 12215535 | ||
| Pubmed | 5.21e-06 | 24 | 49 | 3 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 5.21e-06 | 24 | 49 | 3 | 10078207 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 36464671 | ||
| Pubmed | YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. | 5.83e-06 | 3 | 49 | 2 | 28106072 | |
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 5.83e-06 | 3 | 49 | 2 | 22496871 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15491989 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26286136 | ||
| Pubmed | YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation. | 5.83e-06 | 3 | 49 | 2 | 35508130 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 34497675 | ||
| Pubmed | Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs. | 5.83e-06 | 3 | 49 | 2 | 30333515 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 28901289 | ||
| Pubmed | Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome. | 5.83e-06 | 3 | 49 | 2 | 33397688 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27157388 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 38427913 | ||
| Pubmed | Expression and prognostic values of ARID family members in breast cancer. | 5.83e-06 | 3 | 49 | 2 | 33592583 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24382590 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 33315889 | ||
| Pubmed | A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA. | 5.83e-06 | 3 | 49 | 2 | 32492408 | |
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 5.83e-06 | 3 | 49 | 2 | 26716708 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27989458 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 5.83e-06 | 3 | 49 | 2 | 18093911 | |
| Pubmed | m6A-binding YTHDF proteins promote stress granule formation. | 5.83e-06 | 3 | 49 | 2 | 32451507 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15834131 | ||
| Pubmed | A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection. | 5.83e-06 | 3 | 49 | 2 | 25340845 | |
| Pubmed | PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells. | 5.83e-06 | 3 | 49 | 2 | 28232582 | |
| Pubmed | Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. | 5.83e-06 | 3 | 49 | 2 | 26724866 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 8781769 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31292544 | ||
| Interaction | CRX interactions | TRERF1 TET2 ZFHX4 EP400 ATXN7 BICRA ARID2 PAXIP1 SMARCA2 ZFHX3 QRICH1 ARID1A TFG MED12 | 5.87e-16 | 254 | 48 | 14 | int:CRX |
| Interaction | SP7 interactions | TRERF1 TET2 NCOA6 SATB1 ZFHX4 EP400 BICRA ARID2 PAXIP1 SMARCA2 ARID1A MEF2A MEF2D SCAF4 | 7.13e-15 | 304 | 48 | 14 | int:SP7 |
| Interaction | EGR2 interactions | TRERF1 TET2 NCOA6 ZFHX4 EP400 BICRA ARID2 PAXIP1 SMARCA2 ZFHX3 ARID1A | 2.04e-13 | 171 | 48 | 11 | int:EGR2 |
| Interaction | HNF1B interactions | TET2 SATB1 ZFHX4 EP400 BICRA ARID2 PAXIP1 SMARCA2 ZFHX3 ARID1A MEF2D | 6.52e-13 | 190 | 48 | 11 | int:HNF1B |
| Interaction | SOX2 interactions | TRERF1 YTHDF1 TET2 NCOA6 PPP2R5D SATB1 ZFHX4 EP400 ARID2 TNRC6A PAXIP1 RANBP9 SMARCA2 PUM2 HELZ ZFHX3 ARID1A MEF2A MEF2D PHC2 HNRNPU | 2.01e-12 | 1422 | 48 | 21 | int:SOX2 |
| Interaction | FEV interactions | NCOA6 SATB1 ZFHX4 EP400 BICRA ARID2 PAXIP1 ZFHX3 TAF4 ARID1A | 4.04e-11 | 203 | 48 | 10 | int:FEV |
| Interaction | NFIX interactions | ZFHX4 EP400 BICRA ARID2 PAXIP1 SMARCA2 ZFHX3 QRICH1 TAF4 ARID1A | 1.21e-10 | 227 | 48 | 10 | int:NFIX |
| Interaction | NUP35 interactions | YTHDF1 NCOA6 TNRC6A SMARCA2 PUM2 HELZ QRICH1 ARID1A PUM1 TFG MEF2D YTHDF3 | 2.26e-10 | 424 | 48 | 12 | int:NUP35 |
| Interaction | TEAD1 interactions | 3.01e-10 | 176 | 48 | 9 | int:TEAD1 | |
| Interaction | LHX2 interactions | 4.26e-10 | 183 | 48 | 9 | int:LHX2 | |
| Interaction | AR interactions | TRERF1 TET2 NCOA6 EP400 ARID2 PAXIP1 RANBP9 MED12L SMARCA2 ZFHX3 ARID1A TNS1 MEF2A MED12 MEF2D HNRNPU | 5.37e-10 | 992 | 48 | 16 | int:AR |
| Interaction | PAX9 interactions | 7.33e-10 | 130 | 48 | 8 | int:PAX9 | |
| Interaction | KLF5 interactions | 7.48e-10 | 195 | 48 | 9 | int:KLF5 | |
| Interaction | PAX6 interactions | NCOA6 SATB1 ZFHX4 EP400 BICRA ARID2 PAXIP1 SMARCA2 ZFHX3 QRICH1 ARID1A | 7.56e-10 | 366 | 48 | 11 | int:PAX6 |
| Interaction | TLE3 interactions | TRERF1 FOXJ2 TET2 ARID2 TNRC6A HELZ ZFHX3 QRICH1 TAF4 ARID1A SCAF4 | 1.00e-09 | 376 | 48 | 11 | int:TLE3 |
| Interaction | CEBPA interactions | TRERF1 TET2 NCOA6 EP400 BICRA ARID2 PAXIP1 SMARCA2 BATF3 QRICH1 TAF4 ARID1A MEF2A MED12 MEF2D HNRNPU SCAF4 | 1.70e-09 | 1245 | 48 | 17 | int:CEBPA |
| Interaction | UNK interactions | YTHDF1 TNRC6A RANBP9 PUM2 HELZ FBXO11 ARID1A PUM1 TFG YTHDF3 HNRNPU | 2.36e-09 | 408 | 48 | 11 | int:UNK |
| Interaction | ERG interactions | 2.44e-09 | 223 | 48 | 9 | int:ERG | |
| Interaction | HDAC1 interactions | TRERF1 TET2 SATB1 ZFHX4 EP400 TNRC6A RANBP9 SMARCA2 PHLPP1 GIGYF2 ZFHX3 ARID1A MEF2A MED12 MEF2D HNRNPU | 2.66e-09 | 1108 | 48 | 16 | int:HDAC1 |
| Interaction | SOX9 interactions | 3.01e-09 | 97 | 48 | 7 | int:SOX9 | |
| Interaction | TLX1 interactions | 7.73e-09 | 175 | 48 | 8 | int:TLX1 | |
| Interaction | HNF4A interactions | 1.52e-08 | 275 | 48 | 9 | int:HNF4A | |
| Interaction | PAX7 interactions | 1.68e-08 | 124 | 48 | 7 | int:PAX7 | |
| Interaction | TNRC6A interactions | 1.77e-08 | 280 | 48 | 9 | int:TNRC6A | |
| Interaction | GATA2 interactions | 2.11e-08 | 199 | 48 | 8 | int:GATA2 | |
| Interaction | R3HDM2 interactions | 2.21e-08 | 129 | 48 | 7 | int:R3HDM2 | |
| Interaction | TLX3 interactions | 2.47e-08 | 291 | 48 | 9 | int:TLX3 | |
| Interaction | SOX7 interactions | 4.03e-08 | 82 | 48 | 6 | int:SOX7 | |
| Interaction | IRF4 interactions | 5.01e-08 | 85 | 48 | 6 | int:IRF4 | |
| Interaction | CPEB1 interactions | 5.21e-08 | 146 | 48 | 7 | int:CPEB1 | |
| Interaction | SMG7 interactions | 5.43e-08 | 319 | 48 | 9 | int:SMG7 | |
| Interaction | ANKRD17 interactions | 5.67e-08 | 226 | 48 | 8 | int:ANKRD17 | |
| Interaction | CPEB4 interactions | 8.21e-08 | 156 | 48 | 7 | int:CPEB4 | |
| Interaction | PPIA interactions | NCOA6 EP400 ZFP36L2 ARID2 PAXIP1 RANBP9 SMARCA2 ARID1A TFG MED12 MEF2D YTHDF3 SCAF4 | 9.95e-08 | 888 | 48 | 13 | int:PPIA |
| Interaction | LHX4 interactions | 1.26e-07 | 166 | 48 | 7 | int:LHX4 | |
| Interaction | LHX1 interactions | 1.59e-07 | 103 | 48 | 6 | int:LHX1 | |
| Interaction | KDM1A interactions | TRERF1 TET2 SATB1 ZFHX4 EP400 TNRC6A RANBP9 SMARCA2 GIGYF2 ZFHX3 MED12 MEF2D PHC2 | 1.94e-07 | 941 | 48 | 13 | int:KDM1A |
| Interaction | MED23 interactions | 1.98e-07 | 266 | 48 | 8 | int:MED23 | |
| Interaction | CNOT2 interactions | 2.02e-07 | 178 | 48 | 7 | int:CNOT2 | |
| Interaction | ZFP36 interactions | 2.26e-07 | 181 | 48 | 7 | int:ZFP36 | |
| Interaction | ALG13 interactions | 2.44e-07 | 183 | 48 | 7 | int:ALG13 | |
| Interaction | PAX8 interactions | 2.48e-07 | 111 | 48 | 6 | int:PAX8 | |
| Interaction | LHX3 interactions | 2.63e-07 | 185 | 48 | 7 | int:LHX3 | |
| Interaction | TBR1 interactions | 2.75e-07 | 113 | 48 | 6 | int:TBR1 | |
| Interaction | TNRC6B interactions | 3.09e-07 | 282 | 48 | 8 | int:TNRC6B | |
| Interaction | TBXT interactions | 3.22e-07 | 116 | 48 | 6 | int:TBXT | |
| Interaction | FAM120C interactions | 3.26e-07 | 191 | 48 | 7 | int:FAM120C | |
| Interaction | CELF1 interactions | 3.63e-07 | 288 | 48 | 8 | int:CELF1 | |
| Interaction | SMC5 interactions | YTHDF1 NCOA6 EP400 BICRA ARID2 GIGYF2 TAF4 ARID1A PUM1 MEF2D YTHDF3 HNRNPU SCAF4 | 3.90e-07 | 1000 | 48 | 13 | int:SMC5 |
| Interaction | MEN1 interactions | YTHDF1 NCOA6 PPP2R5D EP400 ZFP36L2 ARID2 PAXIP1 GIGYF2 ARID1A PUM1 MED12 MEF2D YTHDF3 | 5.40e-07 | 1029 | 48 | 13 | int:MEN1 |
| Interaction | RBMS1 interactions | 5.61e-07 | 207 | 48 | 7 | int:RBMS1 | |
| Interaction | PABPC1 interactions | YTHDF1 TET2 ZFP36L2 KAT6A TNRC6A PUM2 GIGYF2 HELZ PUM1 YTHDF3 HNRNPU | 5.66e-07 | 699 | 48 | 11 | int:PABPC1 |
| Interaction | GCM1 interactions | 5.76e-07 | 68 | 48 | 5 | int:GCM1 | |
| Interaction | YTHDF2 interactions | 6.65e-07 | 312 | 48 | 8 | int:YTHDF2 | |
| Interaction | ZC3H7A interactions | 7.25e-07 | 215 | 48 | 7 | int:ZC3H7A | |
| Interaction | TOP3B interactions | YTHDF1 NCOA6 EP400 ZFP36L2 BICRA KAT6A PAXIP1 HELZ KLHL14 ARID1A PUM1 MED12 YTHDF3 PHC2 HNRNPU | 8.99e-07 | 1470 | 48 | 15 | int:TOP3B |
| Interaction | CNOT7 interactions | 9.74e-07 | 140 | 48 | 6 | int:CNOT7 | |
| Interaction | KLF3 interactions | 1.07e-06 | 228 | 48 | 7 | int:KLF3 | |
| Interaction | CNOT9 interactions | 1.17e-06 | 231 | 48 | 7 | int:CNOT9 | |
| Interaction | DAZL interactions | 1.20e-06 | 145 | 48 | 6 | int:DAZL | |
| Interaction | OTUD4 interactions | 1.35e-06 | 236 | 48 | 7 | int:OTUD4 | |
| Interaction | AGO2 interactions | 1.46e-06 | 472 | 48 | 9 | int:AGO2 | |
| Interaction | FAM120A interactions | 1.54e-06 | 349 | 48 | 8 | int:FAM120A | |
| Interaction | AGO3 interactions | 1.64e-06 | 153 | 48 | 6 | int:AGO3 | |
| Interaction | NANOG interactions | 1.71e-06 | 481 | 48 | 9 | int:NANOG | |
| Interaction | FOXI1 interactions | 2.61e-06 | 92 | 48 | 5 | int:FOXI1 | |
| Interaction | RPS20 interactions | 2.90e-06 | 513 | 48 | 9 | int:RPS20 | |
| Interaction | PRRC2B interactions | 2.92e-06 | 265 | 48 | 7 | int:PRRC2B | |
| Interaction | SOX17 interactions | 3.05e-06 | 95 | 48 | 5 | int:SOX17 | |
| Interaction | FMR1 interactions | 4.14e-06 | 536 | 48 | 9 | int:FMR1 | |
| Interaction | AGO1 interactions | 4.62e-06 | 183 | 48 | 6 | int:AGO1 | |
| Interaction | RNF214 interactions | 4.77e-06 | 104 | 48 | 5 | int:RNF214 | |
| Interaction | PUM1 interactions | 4.93e-06 | 287 | 48 | 7 | int:PUM1 | |
| Interaction | RBBP5 interactions | 4.93e-06 | 287 | 48 | 7 | int:RBBP5 | |
| Interaction | GATA3 interactions | 5.23e-06 | 187 | 48 | 6 | int:GATA3 | |
| Interaction | UBAP2L interactions | 6.31e-06 | 298 | 48 | 7 | int:UBAP2L | |
| Interaction | EIF4ENIF1 interactions | 6.59e-06 | 300 | 48 | 7 | int:EIF4ENIF1 | |
| Interaction | CNOT11 interactions | 6.86e-06 | 112 | 48 | 5 | int:CNOT11 | |
| Interaction | PPARG interactions | 7.66e-06 | 307 | 48 | 7 | int:PPARG | |
| Interaction | MED1 interactions | 9.10e-06 | 206 | 48 | 6 | int:MED1 | |
| Interaction | PML interactions | TET2 SATB1 EP400 ATXN7 KAT6A PAXIP1 QRICH1 TAF4 MEF2D YTHDF3 HNRNPU | 9.23e-06 | 933 | 48 | 11 | int:PML |
| Interaction | ETS1 interactions | 1.00e-05 | 121 | 48 | 5 | int:ETS1 | |
| Interaction | EYA2 interactions | 1.00e-05 | 121 | 48 | 5 | int:EYA2 | |
| Interaction | JUN interactions | 1.37e-05 | 470 | 48 | 8 | int:JUN | |
| Interaction | MEX3B interactions | 1.39e-05 | 222 | 48 | 6 | int:MEX3B | |
| Interaction | EP300 interactions | TRERF1 NCOA6 SATB1 ATXN7 KAT6A PAXIP1 SMARCA2 ARID1A PUM1 MEF2A MEF2D HNRNPU SCAF4 | 1.62e-05 | 1401 | 48 | 13 | int:EP300 |
| Interaction | SNRNP40 interactions | 1.66e-05 | 637 | 48 | 9 | int:SNRNP40 | |
| Interaction | TNRC6C interactions | 1.89e-05 | 138 | 48 | 5 | int:TNRC6C | |
| Interaction | BICRA interactions | 1.94e-05 | 67 | 48 | 4 | int:BICRA | |
| Interaction | CNOT10 interactions | 2.10e-05 | 141 | 48 | 5 | int:CNOT10 | |
| Interaction | BMI1 interactions | 2.17e-05 | 659 | 48 | 9 | int:BMI1 | |
| Interaction | ZCCHC2 interactions | 2.17e-05 | 23 | 48 | 3 | int:ZCCHC2 | |
| Interaction | EYA4 interactions | 2.32e-05 | 243 | 48 | 6 | int:EYA4 | |
| Interaction | PUM2 interactions | 2.32e-05 | 144 | 48 | 5 | int:PUM2 | |
| Interaction | YTHDF3 interactions | 2.49e-05 | 246 | 48 | 6 | int:YTHDF3 | |
| Interaction | ELF5 interactions | 2.57e-05 | 147 | 48 | 5 | int:ELF5 | |
| Interaction | ASF1A interactions | 2.66e-05 | 249 | 48 | 6 | int:ASF1A | |
| Interaction | CNOT8 interactions | 2.88e-05 | 74 | 48 | 4 | int:CNOT8 | |
| Interaction | TBP interactions | 2.91e-05 | 253 | 48 | 6 | int:TBP | |
| Interaction | GUSBP5 interactions | 3.04e-05 | 75 | 48 | 4 | int:GUSBP5 | |
| Cytoband | 20q13.33 | 3.26e-03 | 79 | 49 | 2 | 20q13.33 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.23e-12 | 25 | 32 | 6 | 775 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.82e-05 | 4 | 32 | 2 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 3.02e-05 | 5 | 32 | 2 | 1086 | |
| GeneFamily | AT-rich interaction domain containing | 3.14e-04 | 15 | 32 | 2 | 418 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.14e-04 | 15 | 32 | 2 | 529 | |
| GeneFamily | Cyclins|Mediator complex | 1.55e-03 | 33 | 32 | 2 | 1061 | |
| GeneFamily | Forkhead boxes | 2.62e-03 | 43 | 32 | 2 | 508 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.95e-03 | 53 | 32 | 2 | 532 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 PACS1 EP400 ZFP36L2 PHLDA1 ATXN7 ARID2 KAT6A RANBP9 SMARCA2 PUM2 HELZ FBXO11 ARID1A MEF2D HNRNPU | 6.27e-09 | 1492 | 49 | 16 | M40023 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 NCOA6 SPRR1A TNRC6A SMARCA2 GIGYF2 ZFHX3 QRICH1 PUM1 HNRNPU | 1.29e-08 | 467 | 49 | 10 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 NCOA6 SPRR1A TNRC6A SMARCA2 GIGYF2 ZFHX3 QRICH1 PUM1 HNRNPU | 1.81e-08 | 484 | 49 | 10 | MM999 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZFP36L2 KAT6A SMARCA2 PHLPP1 PUM2 GIGYF2 HELZ ZFHX3 TAF4 PUM1 MEF2A YTHDF3 | 4.14e-08 | 856 | 49 | 12 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.37e-06 | 300 | 49 | 7 | M8702 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 1.89e-06 | 199 | 49 | 6 | M3175 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.24e-06 | 466 | 49 | 8 | M13522 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 2.11e-05 | 634 | 49 | 8 | M40866 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 3.57e-05 | 200 | 49 | 5 | M5851 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 3.57e-05 | 200 | 49 | 5 | M5870 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.57e-05 | 200 | 49 | 5 | M9136 | |
| Coexpression | GSE557_WT_VS_I_AB_KO_DC_DN | 3.57e-05 | 200 | 49 | 5 | M6010 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 5.73e-05 | 363 | 49 | 6 | M6315 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 6.40e-05 | 115 | 49 | 4 | M7484 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 6.56e-05 | 372 | 49 | 6 | MM1043 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 9.12e-05 | 126 | 49 | 4 | M39132 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | 1.58e-04 | 845 | 49 | 8 | M18090 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 2.03e-04 | 155 | 49 | 4 | M8944 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 2.21e-04 | 465 | 49 | 6 | M39066 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 2.63e-04 | 166 | 49 | 4 | M7722 | |
| Coexpression | LIU_SOX4_TARGETS_DN | 2.79e-04 | 310 | 49 | 5 | M17287 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 3.36e-04 | 177 | 49 | 4 | M9401 | |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP | 3.36e-04 | 177 | 49 | 4 | M6564 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.58e-04 | 180 | 49 | 4 | M8239 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON | 4.04e-04 | 16 | 49 | 2 | M39025 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 4.05e-04 | 734 | 49 | 7 | M3835 | |
| Coexpression | CARD_MIR302A_TARGETS | 4.07e-04 | 77 | 49 | 3 | M2208 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 4.39e-04 | 190 | 49 | 4 | M8457 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 4.66e-04 | 193 | 49 | 4 | M3303 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP | 4.66e-04 | 193 | 49 | 4 | M9056 | |
| Coexpression | GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN | 4.75e-04 | 194 | 49 | 4 | M9876 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 4.84e-04 | 195 | 49 | 4 | M7382 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN | 5.03e-04 | 197 | 49 | 4 | M5877 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 5.03e-04 | 197 | 49 | 4 | M7921 | |
| Coexpression | NAGY_TFTC_COMPONENTS_HUMAN | 5.14e-04 | 18 | 49 | 2 | M2974 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 5.23e-04 | 199 | 49 | 4 | M9501 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_DN | 5.23e-04 | 199 | 49 | 4 | M4558 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN | 5.23e-04 | 199 | 49 | 4 | M9744 | |
| Coexpression | GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 5.23e-04 | 199 | 49 | 4 | M8211 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 5.23e-04 | 199 | 49 | 4 | M3417 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN | 5.23e-04 | 199 | 49 | 4 | M7321 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP | 5.23e-04 | 199 | 49 | 4 | M4141 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN | 5.33e-04 | 200 | 49 | 4 | M9479 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 5.33e-04 | 200 | 49 | 4 | M9439 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | 5.33e-04 | 200 | 49 | 4 | M3374 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 5.33e-04 | 200 | 49 | 4 | M9354 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 5.33e-04 | 200 | 49 | 4 | M8050 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN | 5.33e-04 | 200 | 49 | 4 | M7075 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP | 5.33e-04 | 200 | 49 | 4 | M4033 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 5.33e-04 | 200 | 49 | 4 | M5227 | |
| Coexpression | GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP | 5.33e-04 | 200 | 49 | 4 | M9622 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP | 5.33e-04 | 200 | 49 | 4 | M9610 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 5.33e-04 | 200 | 49 | 4 | M9041 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 5.33e-04 | 200 | 49 | 4 | M9889 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP | 5.33e-04 | 200 | 49 | 4 | M3778 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP | 5.33e-04 | 200 | 49 | 4 | M9860 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 5.33e-04 | 200 | 49 | 4 | M8854 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 5.33e-04 | 200 | 49 | 4 | M9133 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 6.40e-04 | 568 | 49 | 6 | MM3824 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 7.30e-04 | 94 | 49 | 3 | M18108 | |
| Coexpression | HAN_SATB1_TARGETS_DN | 7.74e-04 | 388 | 49 | 5 | M15491 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 7.87e-04 | 222 | 49 | 4 | M16955 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 8.55e-04 | 227 | 49 | 4 | M11234 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | 1.29e-05 | 343 | 49 | 7 | GSM399400_500 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-08 | 194 | 49 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-08 | 194 | 49 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-08 | 194 | 49 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-06 | 199 | 49 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.81e-05 | 159 | 49 | 4 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.33e-05 | 166 | 49 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 175 | 49 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.86e-05 | 192 | 49 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 193 | 49 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.98e-05 | 193 | 49 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 195 | 49 | 4 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 6.35e-05 | 196 | 49 | 4 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 197 | 49 | 4 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.47e-05 | 197 | 49 | 4 | 51340570667914bffec741c72a8d09cc46abb8e8 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.86e-05 | 200 | 49 | 4 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 4.09e-09 | 178 | 49 | 8 | 579_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.87e-09 | 182 | 49 | 8 | 3887_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.82e-06 | 172 | 49 | 6 | 1072_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.54e-06 | 193 | 49 | 6 | 6749_DN | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 3.54e-06 | 193 | 49 | 6 | 431_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.65e-06 | 194 | 49 | 6 | 6761_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.87e-06 | 196 | 49 | 6 | 5102_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.87e-06 | 196 | 49 | 6 | 4675_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.11e-06 | 198 | 49 | 6 | 4367_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; HL60; HG-U133A | 4.11e-06 | 198 | 49 | 6 | 1775_UP | |
| Drug | AC1O6W2C | 2.06e-05 | 75 | 49 | 4 | CID000446591 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.20e-05 | 170 | 49 | 5 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.48e-05 | 173 | 49 | 5 | 4237_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.67e-05 | 175 | 49 | 5 | 1058_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.78e-05 | 176 | 49 | 5 | 981_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; HL60; HG-U133A | 3.98e-05 | 178 | 49 | 5 | 1716_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.98e-05 | 178 | 49 | 5 | 1112_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.20e-05 | 180 | 49 | 5 | 4541_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 4.43e-05 | 182 | 49 | 5 | 7085_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.67e-05 | 184 | 49 | 5 | 2321_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 4.79e-05 | 185 | 49 | 5 | 1114_DN | |
| Drug | AC1L2E0P | 4.91e-05 | 307 | 49 | 6 | CID000019390 | |
| Drug | Alsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A | 5.17e-05 | 188 | 49 | 5 | 7078_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.44e-05 | 190 | 49 | 5 | 7145_DN | |
| Drug | glutamin | 5.49e-05 | 461 | 49 | 7 | CID000000738 | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 5.71e-05 | 192 | 49 | 5 | 3804_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.85e-05 | 193 | 49 | 5 | 4443_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 5.85e-05 | 193 | 49 | 5 | 6733_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 4738_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 6656_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 6763_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 2096_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 1301_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 3256_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 7317_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 1628_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 4227_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 6732_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 3618_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 2641_DN | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 3247_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5422_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HG-U133A | 6.61e-05 | 198 | 49 | 5 | 1910_UP | |
| Drug | Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 7024_UP | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1319_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 6321_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1890_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 4649_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1472_UP | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 7274_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.93e-05 | 200 | 49 | 5 | 6676_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.93e-05 | 200 | 49 | 5 | 4841_DN | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 6.93e-05 | 200 | 49 | 5 | 3886_UP | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; HL60; HG-U133A | 3.45e-04 | 155 | 49 | 4 | 1786_UP | |
| Drug | 1,1,1-trichloroethane | 3.53e-04 | 156 | 49 | 4 | CID000006278 | |
| Drug | butylurethane | 4.06e-04 | 14 | 49 | 2 | CID000011577 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 5.00e-04 | 171 | 49 | 4 | 7535_DN | |
| Drug | Chloroprene | SATB1 ZFHX4 ATXN7 ARID2 KAT6A RANBP9 QRICH1 PUM1 MEF2A HNRNPU | 5.05e-04 | 1348 | 49 | 10 | ctd:D002737 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.11e-04 | 172 | 49 | 4 | 2330_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.34e-04 | 174 | 49 | 4 | 1659_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; HL60; HG-U133A | 5.46e-04 | 175 | 49 | 4 | 1746_UP | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 5.46e-04 | 175 | 49 | 4 | 1161_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.57e-04 | 176 | 49 | 4 | 6932_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.69e-04 | 177 | 49 | 4 | 7550_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.82e-04 | 178 | 49 | 4 | 4184_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 5.82e-04 | 178 | 49 | 4 | 6193_DN | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A | 6.06e-04 | 180 | 49 | 4 | 5779_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 6.58e-04 | 184 | 49 | 4 | 4610_DN | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 6.86e-04 | 186 | 49 | 4 | 6793_UP | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 7.00e-04 | 187 | 49 | 4 | 7080_DN | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 7.14e-04 | 188 | 49 | 4 | 974_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.28e-04 | 189 | 49 | 4 | 4304_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 7.28e-04 | 189 | 49 | 4 | 1168_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.42e-04 | 190 | 49 | 4 | 3966_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.42e-04 | 190 | 49 | 4 | 5614_DN | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 7.42e-04 | 190 | 49 | 4 | 4452_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.57e-04 | 191 | 49 | 4 | 7339_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 2699_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 6207_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 6102_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 1209_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 6752_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 4129_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 5839_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 4173_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 6646_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 3434_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 7032_UP | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 6647_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 7406_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 6827_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 4246_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 8.02e-04 | 194 | 49 | 4 | 2009_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 7001_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 4772_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 3938_UP | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 2686_DN | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 8.18e-04 | 195 | 49 | 4 | 6701_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | 8.18e-04 | 195 | 49 | 4 | 1296_DN | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.18e-04 | 195 | 49 | 4 | 2230_DN | |
| Disease | Coffin-Siris syndrome | 1.22e-06 | 13 | 49 | 3 | C0265338 | |
| Disease | obesity (implicated_via_orthology) | 1.50e-06 | 215 | 49 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 8.67e-06 | 447 | 49 | 7 | C3714756 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.69e-05 | 5 | 49 | 2 | C3281201 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 4.80e-05 | 801 | 49 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Prostatic Neoplasms | 6.71e-05 | 616 | 49 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 6.71e-05 | 616 | 49 | 7 | C0376358 | |
| Disease | neutrophil count | TRERF1 FOXJ2 TET2 CCDC200 ZFP36L2 ATXN7 TNRC6A KCNN3 ARID1A MEF2D | 7.59e-05 | 1382 | 49 | 10 | EFO_0004833 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.48e-05 | 139 | 49 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 1.36e-04 | 157 | 49 | 4 | DOID:9256 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.41e-04 | 301 | 49 | 5 | DOID:684 (is_marker_for) | |
| Disease | creatinine measurement | 2.15e-04 | 995 | 49 | 8 | EFO_0004518 | |
| Disease | testosterone measurement | 2.20e-04 | 1275 | 49 | 9 | EFO_0004908 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.34e-04 | 181 | 49 | 4 | DOID:684 (is_implicated_in) | |
| Disease | risk-taking behaviour | 2.53e-04 | 764 | 49 | 7 | EFO_0008579 | |
| Disease | age at menarche | 4.35e-04 | 594 | 49 | 6 | EFO_0004703 | |
| Disease | neutrophil percentage of leukocytes | 5.01e-04 | 610 | 49 | 6 | EFO_0007990 | |
| Disease | Neurodevelopmental Disorders | 5.03e-04 | 93 | 49 | 3 | C1535926 | |
| Disease | disease of metabolism (implicated_via_orthology) | 5.56e-04 | 21 | 49 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 6.21e-04 | 100 | 49 | 3 | C0010606 | |
| Disease | lifestyle measurement | 6.27e-04 | 235 | 49 | 4 | EFO_0010724 | |
| Disease | Sezary Syndrome | 9.23e-04 | 27 | 49 | 2 | C0036920 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 9.93e-04 | 28 | 49 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 1.30e-03 | 32 | 49 | 2 | EFO_0007663, EFO_0007826 | |
| Disease | colon cancer (is_implicated_in) | 1.64e-03 | 36 | 49 | 2 | DOID:219 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPQPQPQTQPQPVQA | 2581 | Q96L91 | |
| AQQPPPPPQQQQQQQ | 351 | Q5SZQ8 | |
| PPPQQVQVQVQQPQQ | 1021 | Q68CP9 | |
| AQPQPQPQPQPQAQS | 36 | Q14738 | |
| QPQPQPQAQSQPPSS | 41 | Q14738 | |
| VAAPGNQPQPQPQQQ | 16 | Q9NR55 | |
| QSQQQPPQQQPSPQP | 516 | Q9UBL0 | |
| PPQQQPSPQPQQQVQ | 521 | Q9UBL0 | |
| PPPPPQQQQQQQQLS | 6 | Q96S59 | |
| QQQQQQQQLSPPPPA | 11 | Q96S59 | |
| QPQQQTPQEQTPPPQ | 421 | Q2TAL8 | |
| TPQEQTPPPQQQQQQ | 426 | Q2TAL8 | |
| PIGTQPPQQQQQQPS | 501 | Q8TB72 | |
| QQQQLPPAQPQPASQ | 1401 | O14497 | |
| QQQQISQQPYPQQPP | 431 | Q6ZW49 | |
| QQPPQQQQQQQPPPS | 571 | Q6ZW49 | |
| SQPPQQPPQQSQPQQ | 196 | Q5VYV0 | |
| PQPQQPPQPQQSSQS | 2071 | Q86YW9 | |
| GPSLQPQPPQLQQQQ | 56 | Q9UGI6 | |
| QQPQPPATQQQQPQQ | 161 | Q00839 | |
| QQQAAPPQPQPQSQP | 2121 | Q93074 | |
| PPQPQPQSQPQFQRQ | 2126 | Q93074 | |
| QQQQQQPPQPPPQQS | 301 | Q9P0K8 | |
| QPPQPPPQQSQPQQQ | 306 | Q9P0K8 | |
| QQQQQQQQQQPPPPP | 421 | Q02078 | |
| PNQIPPQPNQVVQQQ | 1391 | P42694 | |
| QQQQQQQQQPPPPQP | 31 | O15265 | |
| QQQQPPPPQPQRQQH | 36 | O15265 | |
| QQQQQPPQQPTPPKL | 36 | Q6VY07 | |
| RPLGTQQPQPQPQQQ | 621 | Q14671 | |
| QQPQPQPQQQPNNNL | 626 | Q14671 | |
| PQQQPQPQLPQQQQP | 1001 | Q14686 | |
| QQQQPPPPSQPQSQQ | 1011 | Q14686 | |
| QQQPQQQPQPQPQQP | 1676 | Q92794 | |
| PKDQQQPPQQQPSQQ | 81 | Q9P2G3 | |
| QPPQQQPSQQQQPPP | 86 | Q9P2G3 | |
| QEQPQPSQQQPSVQP | 71 | A0A1B0GVQ3 | |
| QQQQQQPPQQPPQQP | 1211 | Q6Y7W6 | |
| QPPQQPPQQPQQQDS | 1216 | Q6Y7W6 | |
| RPRPVQQQQQQPPQQ | 16 | Q86XK2 | |
| QPQAQQPPQAPTPQA | 641 | Q9NZM4 | |
| QQPPQQPQQQPQPQA | 941 | O95104 | |
| QPQQQPQPQAPQQPQ | 946 | O95104 | |
| PQQPQQQQQQQPPPS | 956 | O95104 | |
| QQQQQQPPPSQQPPP | 961 | O95104 | |
| QQPPPTQQQPQQFRN | 971 | O95104 | |
| PQQPQQPQQPPQQQS | 391 | Q14814 | |
| LPQPPQNPTNIQNFQ | 436 | O00268 | |
| QQPPQPQTQQQQQPA | 241 | P51531 | |
| QQQQQQQAPPPPQPQ | 601 | Q01826 | |
| SQLPQQQPQPPQPQQ | 316 | Q7Z739 | |
| QQPQPPQPQQQQGPQ | 321 | Q7Z739 | |
| PQPQQQQGPQPQAQP | 326 | Q7Z739 | |
| QQQPQPQQQQPPPQQ | 351 | Q8IXK0 | |
| TQPQLQPQKQQQQPP | 1761 | Q86UP3 | |
| QPQKQQQQPPPPQQQ | 1766 | Q86UP3 | |
| QQPQAPPQQPQQYGI | 256 | Q92734 | |
| QPQPQPQSQPQPQPQ | 326 | Q8WV24 | |
| QKQPCTPPPQPQQQQ | 6 | P35321 | |
| PQQQQVKQPCQPPPQ | 16 | P35321 | |
| QQQQQQQQQPRPPPR | 651 | Q9HBL0 | |
| QQPPQTQPQQPQPPQ | 6 | Q9P2F9 | |
| HQEQQQQQQPPPPPQ | 1681 | O60346 | |
| QQPQPLQKQPPQPQQ | 1526 | Q6N021 | |
| QQQQQQGLAPPAQPP | 396 | P47974 | |
| QPQQQQPQQQPQALP | 116 | Q8NDV7 | |
| PQQAPSPQAAPQPQQ | 286 | Q9BYJ9 | |
| GPQQPPQQQQQQQQP | 3191 | Q15911 | |
| QPPPQQQQPQQLQLQ | 301 | Q96PN7 |